ABC Family Arquivos Brasileiros de Cardiologia International Journal of Cardiovascular Sciences ABC Heart Failure & Cardiomyopathy ABC Imagem Cardiovascular
Português English
ABC Family
Português English
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News

ABC Family

  • ABC Family
  • Arquivos Brasileiros de Cardiologia
  • International Journal of Cardiovascular Sciences
  • ABC Heart Failure & Cardiomyopathy
  • ABC Imagem Cardiovascular
Search in

No content found.

Journals
Ordering
Article types
Others

  1. Home
  2. Keyword: Ezetimibe, Simvastatin Drug Combination
Figure 1
ABC
Viewpoint

Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk

Paulo Eduardo Ballvé Behr et al. Emilio Hideyuki Moriguchi Iran Castro Luiz Carlos Bodanese … Oscar Pereira Dutra Paulo Ernesto Leães Pedro Pimentel Filho

LDL-C as a risk factor

The causality of plasma LDL-C levels and reduced LDL-C uptake mediated by the LDL-C receptor in the pathophysiology of CVD has been very consistently established. For patients at very high risk for premature events, such as those with familial hypercholesterolemia (FH), an elevated LDL-C level is an extremely prevalent risk factor.

[…]

  • Cardiovascular Diseases, mortality
  • Cardiovascular Diseases/complications
  • Coronary Artery Disease
  • Ezetimibe, Simvastatin Drug Combination
  • Hyperlipoproteinemia Type II
  • Proprotein Convertase 9
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
01/07/2018 DOI: 10.5935/abc.20180133 Views 1

How to cite this article

EndNote RIS

Electronic Document Format (Vancouver)

Behr PEB, Moriguchi EH, Castro I, Bodanese LC, Dutra OP, Leães PE, Pimentel Filho P, et al. Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk. Arquivos Brasileiros de Cardiologia 2018;111(1):104-8.

Electronic Document Format (ABNT)

Behr, Paulo Eduardo Ballvé; Moriguchi, Emilio Hideyuki; Castro, Iran; Bodanese, Luiz Carlos; Dutra, Oscar Pereira; Leães, Paulo Ernesto; Pimentel Filho, Pedro. Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk. Arquivos Brasileiros de Cardiologia, v. 111, n. 1, p. 104-108, Jun. 2018.

Electronic Document Format (APA)

Behr, P. E. B., Moriguchi, E. H., Castro, I., Bodanese, L. C., Dutra, O. P., Leães, P. E., & Pimentel Filho, P. (2018). Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk. Arquivos Brasileiros de Cardiologia, 111(1), 104-108.

Electronic Document Format (ISO)

Behr, Paulo Eduardo Ballvé and Moriguchi, Emilio Hideyuki and Castro, Iran and Bodanese, Luiz Carlos and Dutra, Oscar Pereira and Leães, Paulo Ernesto and Pimentel Filho, Pedro. Indications of PCSK9 Inhibitors for Patients at High and Very High Cardiovascular Risk. Arquivos Brasileiros de Cardiologia [online]. 2018, vol. 111, n. 1, [cited 2026-10-14], pp. 104-108. Available from: <https://journals.cardiol.br/en/article/indications-of-pcsk9-inhibitors-for-patients-at-high-and-very-high-cardiovascular-risk/>. ISSN 0066-782X

  • About ABC Family
  • Internal Regulation
  • Editorial Board
  • Brazilian Society of Cardiology (SBC)

Issues

SBC Guidelines

  • Videos
  • Podcasts
  • News